SCM
AMED

Segantii Capital Management’s Amedisys AMED Stock Holding History

Segantii Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$38.7M Buy
420,000
+75,205
+22% +$7.05M 2.52% 11
2023
Q4 		$32.8M Buy
+344,795
New +$32.2M 1.72% 16

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Segantii Capital Management's AMED Position: Q1 2024 in Review

Segantii Capital Management increased its Amedisys (AMED) stake by 22% in Q1 2024, buying an estimated $7.05M and bringing the position to 420,000 shares worth $38.7M. The position accounts for 2.52% of the portfolio, ranked #11.

Segantii Capital Management first reported a position in AMED in Q4 2023 and has held it in 2 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Segantii Capital Management held 420,000 shares of Amedisys worth $38.7M as of Q1 2024.
  • Segantii Capital Management bought 75,205 Amedisys shares in Q1 2024, an estimated $7.05M.
  • Amedisys made up 2.52% of Segantii Capital Management's portfolio in Q1 2024, its #11 holding.
  • Segantii Capital Management first reported a position in Amedisys in Q4 2023 and has held it in 2 quarters since.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Segantii Capital Management's 13F filing for Q1 2024, filed 14 May 2024.